Glaucoma care optimised in an ageing population

Christiaan Wesselink

Glaucoma care optimised in an ageing population

Christiaan Wesselink

Onderzoeksoutput

1440 Downloads (Pure)

Samenvatting

Glaucoom is een aandoening waarbij de zenuwvezels van de oogzenuw te snel afsterven, met als belangrijkste risicofactor een hoge oogdruk. Dit afsterven van zenuwvezels resulteert in gezichtsveldverlies die kan leiden tot blindheid. Glaucoom is al de belangrijkste oorzaak van onomkeerbare blindheid in de wereld. Glaucoom komt vooral voor bij de oudere medemens en door de vergrijzing zal het aantal mensen met glaucoom wereldwijd naar schatting toenemen naar 112 miljoen in 2040. Glaucoomzorg zal dus een steeds grotere druk geven op de gezondheidszorg. In het proefschrift 'Glaucoma care optimised in an ageing population' worden mogelijkheden gezocht om de glaucoomzorg te optimaliseren. Zo wordt een effectieve methode van gezichtsveld-monitoring beschreven, worden risicofactoren voor glaucoomprogressie beschreven (hogere leeftijd, hogere oogdruk en meer gezichtsvelduitval) en worden alternatieven of verbeteringen onderzocht voor het soms erg belastende gezichtsveldonderzoek. Ook wordt beschreven of het wellicht mogelijk is om de oudere glaucoompatiënt minder intensief te monitoren of te behandelen zonder dat dit grote risico's met zich meebrengt. Omdat glaucoom een langzaam progressieve aandoening is kunnen patiënten van boven de tachtig met maar weinig gezichtsvelduitval soms minder intensief gevolgd worden zonder het risico dat zij blind worden.

Originele taal-2	English
Kwalificatie	Doctor of Philosophy
Toekennende instantie	Rijksuniversiteit Groningen
Begeleider(s)/adviseur	Jansonius, Nomdo, Supervisor Hooymans, Johanna M.M., Supervisor
Datum van toekenning	22-nov.-2017
Plaats van publicatie	[Groningen]
Uitgever	Rijksuniversiteit Groningen
Gedrukte ISBN's	978-94-034-0235-2
Elektronische ISBN's	978-94-034-0234-5
Status	Published - 2017

Toegang tot document

Title and contentsFinal publisher's version, 146 KB
Chapter 1Final publisher's version, 392 KB
Chapter 2Final publisher's version, 244 KB
Chapter 3Final publisher's version, 163 KB
Chapter 4Final publisher's version, 3,05 MB
Chapter 5Final publisher's version, 844 KB
Chapter 6Final publisher's version, 356 KB
Publisher version chapter 7Final publisher's version, 627 KB
Chapter 8Final publisher's version, 93,2 KB
Nederlandse SamenvattingFinal publisher's version, 75,6 KB
DankwoordFinal publisher's version, 60,9 KB
About the authorFinal publisher's version, 46,8 KB
PropositionsFinal publisher's version, 21,2 KB

Handle.net

Permanente koppeling

Document onder embargo

Chapter 7
Final publisher's version, 638 KB
Embargo eindigt: 01/01/9999

Document onder embargo

Complete thesis
Final publisher's version, 5,4 MB
Embargo eindigt: 01/01/9999

Citeer dit

@phdthesis{73f9c240be6f400eaa6c469f4542dba0,

title = "Glaucoma care optimised in an ageing population",

abstract = "With an estimated number of 64.3 million people having the disease worldwide, glaucoma is the leading cause of irreversible blindness. Glaucoma is a disease of the optic nerve, in which nerve fibers loss leads to visual field loss. The most important risk factor for having the disease is a high intraocular pressure. Age is another well established risk factor and with a growing elderly population worldwide, it is estimated that the number of people with glaucoma will to 112 million in 2040. Thus, the need for glaucoma care will increase. In the thesis 'Glaucoma care optimised in an ageing population', opportunities to optimise glaucoma care are investigated. A novel algorithm is described to easily analyze a series of visual field examinations for glaucoma progression. Risk factors for glaucoma progression (higher age, higher intraocular pressure and more advanced disease stage) are described. Visual field testing can be challenging for patients and ways to improve testing strategies and alternatives to visual field testing are investigated. Furthermore, it is described if elderly glaucoma patients can be monitored or treated less intensively than their younger peers. Since glaucoma is a slowly progressive disease, this is true for patients aged over 80 years with early glaucoma.",

author = "Christiaan Wesselink",

year = "2017",

language = "English",

isbn = "978-94-034-0235-2",

publisher = "Rijksuniversiteit Groningen",

school = "University of Groningen",

}

TY - BOOK

T1 - Glaucoma care optimised in an ageing population

AU - Wesselink, Christiaan

PY - 2017

Y1 - 2017

N2 - With an estimated number of 64.3 million people having the disease worldwide, glaucoma is the leading cause of irreversible blindness. Glaucoma is a disease of the optic nerve, in which nerve fibers loss leads to visual field loss. The most important risk factor for having the disease is a high intraocular pressure. Age is another well established risk factor and with a growing elderly population worldwide, it is estimated that the number of people with glaucoma will to 112 million in 2040. Thus, the need for glaucoma care will increase. In the thesis 'Glaucoma care optimised in an ageing population', opportunities to optimise glaucoma care are investigated. A novel algorithm is described to easily analyze a series of visual field examinations for glaucoma progression. Risk factors for glaucoma progression (higher age, higher intraocular pressure and more advanced disease stage) are described. Visual field testing can be challenging for patients and ways to improve testing strategies and alternatives to visual field testing are investigated. Furthermore, it is described if elderly glaucoma patients can be monitored or treated less intensively than their younger peers. Since glaucoma is a slowly progressive disease, this is true for patients aged over 80 years with early glaucoma.

AB - With an estimated number of 64.3 million people having the disease worldwide, glaucoma is the leading cause of irreversible blindness. Glaucoma is a disease of the optic nerve, in which nerve fibers loss leads to visual field loss. The most important risk factor for having the disease is a high intraocular pressure. Age is another well established risk factor and with a growing elderly population worldwide, it is estimated that the number of people with glaucoma will to 112 million in 2040. Thus, the need for glaucoma care will increase. In the thesis 'Glaucoma care optimised in an ageing population', opportunities to optimise glaucoma care are investigated. A novel algorithm is described to easily analyze a series of visual field examinations for glaucoma progression. Risk factors for glaucoma progression (higher age, higher intraocular pressure and more advanced disease stage) are described. Visual field testing can be challenging for patients and ways to improve testing strategies and alternatives to visual field testing are investigated. Furthermore, it is described if elderly glaucoma patients can be monitored or treated less intensively than their younger peers. Since glaucoma is a slowly progressive disease, this is true for patients aged over 80 years with early glaucoma.

M3 - Thesis fully internal (DIV)

SN - 978-94-034-0235-2

PB - Rijksuniversiteit Groningen

CY - [Groningen]

ER -

Glaucoma care optimised in an ageing population

Samenvatting

Toegang tot document

Handle.net

Document onder embargo

Document onder embargo

Vingerafdruk

Citeer dit